Agenda

Jay Schnitzer, M.D., Ph.D., Director, Frederick National Laboratory for Cancer Research 

Jeff Allen, Ph.D. serves as the President and CEO of Friends of Cancer Research (Friends). For over 25 years, Friends has created unique scientific partnerships, accelerated policy change, and supported groundbreaking research to deliver new therapies to patients quickly and safely. As a key thought leader on issues related to the U.S. Food and Drug Administration, healthcare, and regulatory policy, he is regularly published in prestigious medical journals and policy publications and has contributed his expertise to the legislative process on multiple occasions. Prior to joining Friends, Jeff was an endocrinology/oncology researcher at the National Institutes of Health and received his Ph.D. in cell and molecular biology from Georgetown University.

Carlos Sandi, Volunteer Advocate, Baldrick’s Foundation

• Patient-Derived Models Repository (PDMR), presented by Yvonne Evrard, Ph.D., PDMR Operations Manager, In Vivo Evaluation Program, Frederick National Laboratory for Cancer Research  
• Antibody Characterization Lab, presented by Simona Colantonio, Ph.D., Director of Scientific Operations, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research  

• Deborah Hemingway, Ph.D., Managing Partner, Ecphora Capital 

TEDCO 

• Moderator: Vladimir Popov, Ph.D., MBA, Chief Innovation Officer, Center for Innovation and Strategic Partnerships, Frederick National Laboratory for Cancer Research
• Amanda Corbel, Senior Manager, Innovation, Partnerships and Communication, Center for Innovation and Strategic Partnerships, Frederick National Laboratory for Cancer Research
• [Announcing full panel soon!] 

“A Quantitative Particle Identification (QPID) spectral autoradiography system” by Stephen Adler, Ph.D., Imaging Scientist, Clinical Research Directorate, Frederick National Laboratory for Cancer Research 

Javeed Froozan, BS, MBA, VP, Research, Business Development & Strategic Alliances, Blood Cancer United

• Moderator: Maggie Scully, Ph.D., Partnership Development Officer Director, Frederick National Laboratory for Cancer Research  
• Vinay Vyas, Ph.D., Head of Research and Development, Biopharmaceutical Development Program, Frederick National Laboratory for Cancer Research 
• [Announcing full panel soon!] 

Michael Salgaller, Ph.D., Unit Supervisor, Technology Analysis and Marketing Unit, Technology Transfer Center, National Cancer Institute